ArticleBrain, behavior, & immunity - health2026
Neural response to reward as a potential pathway from inflammation to anhedonia in adolescents at risk for depression.
Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Depression in adolescents has been associated with high levels of circulating inflammatory markers, with a putative mechanism including disrupted function in neural reward circuitry leading to anhedonia, a symptom that involves difficulty with motivation or enjoyment of pleasant experiences. Adolescence provides an opportunity to examine these pathways, as it is the time of onset of anhedonia and depression, and developmental changes in the immune system and reward circuitry. This study used a high-risk design to examine whether development of depression and anhedonia in 45 healthy adolescents (age 13-19) is related to higher levels of inflammatory markers via response in neural reward circuitry. Depression and anhedonia were assessed at enrollment and 6 months later, with a subset of participants completing additional assessment approximately 1 year after study entry. At baseline, adolescents completed a functional magnetic resonance imaging monetary reward task and provided blood samples for assessment of serum levels of tumor necrosis factor-alpha (TNF- α), interleukin-6 (IL-6), and C-reactive protein (CRP). Higher levels of TNF-α and CRP were associated with lower depression and anhedonia severity at baseline and 6-month follow-up, respectively. Higher response in rostral anterior cingulate cortex/medial prefrontal cortex partially statistically mediated the association between baseline CRP level and anhedonia severity 6 months later. Adolescents who were assessed 1 year later did not exhibit higher anhedonia severity at that time point, suggesting that findings could reflect a mechanism of resilience. This study provides a step toward understanding the interplay of inflammation and neural reward circuitry in the development of anhedonia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.